Steven Chmura to Glioblastoma
This is a "connection" page, showing publications Steven Chmura has written about Glioblastoma.
Connection Strength
0.571
-
NRG/RTOG 1122: A phase 2, double-blinded, placebo-controlled study of bevacizumab with and without trebananib in patients with recurrent glioblastoma or gliosarcoma. Cancer. 2020 06 15; 126(12):2821-2828.
Score: 0.155
-
Management of glioblastoma in elderly patients. J Neurol Sci. 2017 Sep 15; 380:250-255.
Score: 0.130
-
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study. J Neurooncol. 2016 Jan; 126(2):309-16.
Score: 0.115
-
Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012 Mar; 107(1):207-12.
Score: 0.087
-
Molecular heterogeneity in glioblastoma: therapeutic opportunities and challenges. Semin Oncol. 2011 Apr; 38(2):243-53.
Score: 0.084